Annual Cost Burden by Level of Relapse Severity in Patients with Multiple Sclerosis

por Nicholas, Jacqueline, Zhou, Huanxue, Deshpande, Chinmay
Publicado 2020

Balancing Potential Benefits and Risks of Bruton Tyrosine Kinase Inhibitor Therapies in Multiple Sclerosis During the COVID-19 Pandemic

por Weber, Martin S., Nicholas, Jacqueline A., Yeaman, Michael R.
Publicado 2021

Burden of relapsing-remitting multiple sclerosis on workers in the US: a cross-sectional analysis of survey data

por Nicholas, Jacqueline A., Electricwala, Batul, Lee, Lulu K., Johnson, Kristen M.
Publicado 2019

Design of oral agents for the management of multiple sclerosis: benefit and risk assessment for dimethyl fumarate

por Nicholas, Jacqueline Ann, Boster, Aaron Lee, Imitola, Jaime, O’Connell, Colleen, Racke, Michael Karl
Publicado 2014

Real-world adherence to, and persistence with, once- and twice-daily oral disease-modifying drugs in patients with multiple sclerosis: a systematic review and meta-analysis

por Nicholas, Jacqueline A., Edwards, Natalie C., Edwards, Roger A., Dellarole, Anna, Grosso, Megan, Phillips, Amy L.
Publicado 2020

Pandemic forward: Lessons learned and expert perspectives on multiple sclerosis care in the COVID-19 era

por Nicholas, Jacqueline A., Shin, Robert K, Alvarez, Enrique, Hendin, Barry, Nair, Kavita V., Lublin, Fred D.
Publicado 2021

Comparative Effectiveness Research of Disease-Modifying Therapies for the Management of Multiple Sclerosis: Analysis of a Large Health Insurance Claims Database

por Boster, Aaron, Nicholas, Jacqueline, Wu, Ning, Yeh, Wei-Shi, Fay, Monica, Edwards, Michael, Huang, Ming-Yi, Lee, Andrew
Publicado 2017

Comparison of Disease-Modifying Therapies for the Management of Multiple Sclerosis: Analysis of Healthcare Resource Utilization and Relapse Rates from US Insurance Claims Data

por Nicholas, Jacqueline, Boster, Aaron, Wu, Ning, Yeh, Wei-Shi, Fay, Monica, Kendter, Jon, Huang, Ming-Yi, Lee, Andrew
Publicado 2017

Static and group-based trajectory analyses of factors associated with non-adherence in patients with multiple sclerosis newly-initiating once- or twice-daily oral disease-modifying...

por Nicholas, Jacqueline A, Edwards, Natalie C, Edwards, Roger A, Dellarole, Anna, Manca, Luigi, Harlow, Danielle E, Phillips, Amy L
Publicado 2022

TRACking health behaviors in people with Multiple Sclerosis (TRAC-MS): Study protocol and description of the study sample

por Prakash, Ruchika S., Manglani, Heena R., Duraney, Elizabeth J., Shankar, Anita, Fisher, Megan E., Janssen, Alisha, Cea, Lauren, Petosa, Rick, Andridge, Rebecca, Nicholas, Jacqueline
Publicado 2022

Satisfaction with alemtuzumab in relapsing multiple sclerosis patients: Results from the real-world PRO-ACT study

por Wray, Sibyl, Jacques, Francois, Miller, Tamara A, Nicholas, Jacqueline A, Arroyo, Rafael, Travis, Lori, Khatri, Bhupendra, Chirieac, Magdalena, Gandhi, Roopali, Roesch, Nora, Rodrigues, Amelie, Melas-Melt, Lydie, Rawlings, Andreea M, Hunter, Samuel F
Publicado 2022

Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health Solutions

por Cohen, Jeffrey A, Bermel, Robert A, Grossman, Cynthia I, Hersh, Carrie M, Hyland, Megan, Mowry, Ellen M, Naismith, Robert, Naylor, Maria L, Nicholas, Jacqueline, Rajbhandar, Rajani, Singh, Carol M, Tintorè, Mar, Zabalza, Ana, Ziemssen, Tjalf, Williams, James R, Montalban, Xavier
Publicado 2022

Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 years

por Hauser, Stephen L, Cross, Anne H, Winthrop, Kevin, Wiendl, Heinz, Nicholas, Jacqueline, Meuth, Sven G, Giacomini, Paul S, Saccà, Francesco, Mancione, Linda, Zielman, Ronald, Bagger, Morten, Das Gupta, Ayan, Häring, Dieter A, Jehl, Valentine, Kieseier, Bernd C, Pingili, Ratnakar, Stoneman, Dee, Su, Wendy, Willi, Roman, Kappos, Ludwig
Publicado 2022

Associations of sNfL with clinico‐radiological measures in a large MS population

por Sotirchos, Elias S., Fitzgerald, Kathryn C., Singh, Carol M., Smith, Matthew D., Reyes‐Mantilla, Maria, Hersh, Carrie M., Hyland, Megan H., Canissario, Ryan, Simmons, Sarah B., Arrambide, Georgina, Montalban, Xavier, Comabella, Manuel, Naismith, Robert T., Qiao, Min, Krupp, Lauren B., Nicholas, Jacqueline A., Akgün, Katja, Ziemssen, Tjalf, Rudick, Richard, Fisher, Elizabeth, Bermel, Robert A., Mowry, Ellen M., Calabresi, Peter A.
Publicado 2022

Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS)

por Mowry, Ellen M., Bermel, Robert A., Williams, James R., Benzinger, Tammie L. S., de Moor, Carl, Fisher, Elizabeth, Hersh, Carrie M., Hyland, Megan H., Izbudak, Izlem, Jones, Stephen E., Kieseier, Bernd C., Kitzler, Hagen H., Krupp, Lauren, Lui, Yvonne W., Montalban, Xavier, Naismith, Robert T., Nicholas, Jacqueline A., Pellegrini, Fabio, Rovira, Alex, Schulze, Maximilian, Tackenberg, Björn, Tintore, Mar, Tivarus, Madalina E., Ziemssen, Tjalf, Rudick, Richard A.
Publicado 2020

Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study

por Bar-Or, Amit, Wiendl, Heinz, Montalban, Xavier, Alvarez, Enrique, Davydovskaya, Maria, Delgado, Silvia R, Evdoshenko, Evgeniy P, Giedraitiene, Natasa, Gross-Paju, Katrin, Haldre, Sulev, Herrman, Craig E, Izquierdo, Guillermo, Karelis, Guntis, Leutmezer, Fritz, Mares, Miroslav, Meca-Lallana, Jose E, Mickeviciene, Dalia, Nicholas, Jacqueline, Robertson, Derrick S, Sazonov, Denis V, Sharlin, Kenneth, Sundaram, Bharathy, Totolyan, Natalia, Vachova, Marta, Valis, Martin, Bagger, Morten, Häring, Dieter A, Ludwig, Inga, Willi, Roman, Zalesak, Martin, Su, Wendy, Merschhemke, Martin, Fox, Edward J
Publicado 2021